Flu’s response to Xofluza explored
Scientists are now investigating the Xofluza mode of action in detail and have uncovered possible mechanisms by which viral resistance to it could emerge...
List view / Grid view
Scientists are now investigating the Xofluza mode of action in detail and have uncovered possible mechanisms by which viral resistance to it could emerge...
A study has found a novel mechanism underlying stable, durable blood sugar control...
Anti-CTLA-4 treatment triggers immune-suppressing EZH2 on T cells; clinical trial open...
Scotland is the first country in the UK to enable patients, battling this serious and debilitating condition, access to a new treatment option...
Findings may represent simple and potentially low-cost intervention...
Once-daily oral pill could replace preoperative chemotherapy in patient population if validated in larger trials...
People who take immunosuppressants are less likely to develop Parkinson's disease...
An FDA-approved drug for lymphoma and leukaemia may also help treat the most common - and deadliest type of brain tumour...
The FDA has accepted the NDA and granted Priority Review for larotrectinib for advanced or metastatic solid tumours harbouring a NTRK gene fusion...
Protein inhibits inflammatory response underlying chronic pain processing may provide an alternative to opioids for severe, persistent pain...
Nanoparticles carrying two drugs can cross the blood-brain barrier and shrink glioblastoma tumours...
Novel enzyme therapy for adults with PKU who have uncontrolled blood phenylalanine concentrations with current treatment...
First proof-of-concept study shows AMG 714 (anti-IL-15 monoclonal antibody) potentially protects celiac patients from inadvertent gluten exposure
Prolonged use of antidepressants may lead to increased risk of weight gain...
The FDA has approved the use of Prolia for the treatment of glucocorticoid-induced osteoporosis (GIOP) in men and women at high risk of fracture...